Description

7H-Isoquino(2,1-D)(1,4)Benzodiazepin-8-Ium, 9,10-Dihydro-6-(p-Bromophe Nyl)-3-Chl is a high-purity, complex heterocyclic organic compound that serves as a critical advanced intermediate in modern pharmaceutical synthesis. Its unique fused benzodiazepine-isoquinoline structure makes it a valuable building block for the development of novel active pharmaceutical ingredients (APIs) and for specialized research applications. This compound is primarily utilized by R&D chemists and process development scientists in the pharmaceutical, biotechnology, and fine chemical sectors.

Application

• Pharmaceutical Intermediate: Key precursor in the synthesis of novel benzodiazepine and isoquinoline-based therapeutic agents.
• Medicinal Chemistry Research: Building block for structure-activity relationship (SAR) studies and the discovery of new bioactive molecules.
• Process Chemistry Development: Used in route scouting and optimization for the scalable production of complex drug candidates.
• Reference Standard: Serves as a high-purity analytical standard for quality control and method development in API manufacturing.
• Academic & Institutional Research: Employed in universities and research institutes for exploring new heterocyclic chemistry and reaction methodologies.
• Custom Synthesis: Starting material for the contract manufacturing of specialized, low-volume fine chemicals for client-specific projects.

Basic Information

Product Name	7H-Isoquino(2,1-D)(1,4)Benzodiazepin-8-Ium, 9,10-Dihydro-6-(p-Bromophe Nyl)-3-Chl
CAS No.	82808-82-0
Molecular Formula	C23H15BrClN3
Molecular Weight	448.74 g/mol
Synonyms	9,10-Dihydro-6-(4-bromophenyl)-3-chloro-7H-isoquino[2,1-d][1,4]benzodiazepin-8-ium; 6-(p-Bromophenyl)-3-chloro-9,10-dihydro-7H-isoquino[2,1-d][1,4]benzodiazepin-8-ium; 82808-82-0; p-Bromophenyl-substituted benzodiazepino-isoquinolinium salt; 3-Chloro-6-(4-bromophenyl)-9,10-dihydroisoquino[2,1-d][1,4]benzodiazepin-8-ium
EINECS	Contact for details

Quality Control

Our production of 7H-Isoquino(2,1-D)(1,4)Benzodiazepin-8-Ium, 9,10-Dihydro-6-(p-Bromophe Nyl)-3-Chl adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity suitable for research and development. All materials are characterized using advanced analytical techniques including HPLC, NMR, and mass spectrometry. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with each shipment to support your regulatory and quality documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). The compound may be light-sensitive and should be handled accordingly to maintain stability.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.